Dr. Xuejun Parsons received PhD in Biochemistry, Molecular, and Cell Biology from Cornell University and completed PostDoc studies as a Leukemia and Lymphoma Society Research Fellow at University of California at San Diego. She has a broad background in biomedical research and life sciences industry, with a great deal of expertise and leadership in the emerging technology of pluripotent human embryonic stem cell (hESC) based regenerative medicine, in-depth understanding of hESC research to the advance of medicine and improvement of human health, and entrepreneurship. Following her postdoc training in the field of molecular biology, she was awarded NIH grants for her career transition into the human stem cell field as PI. Previously, she served as the key personnel and project leader in one of the NIH exploratory centers for pluripotent hESC research, and have led the collaborative effort to develop the utility of hESC as a model system for a diverse range of biological and medical problems with her original research and ability to integrate diverse sources of information to develop novel approaches. She is the Co-Founder/CEO of several Regenerative Medicine startups, and inventor of the emerging PluriXcel technology of regenerative medicine for large-scale production of high quality clinical-grade hESC lines and their functional human neuronal and cardiomyocyte cell therapy derivatives for commercial and therapeutic uses, which has overcome some major obstacles in bringing hESC therapy derivatives towards clinical applications for unmet medical challenges in incurable or hitherto untreatable neurological and heart diseases. Her original hPSC research breakthroughs render well-controlled high efficient neuronal or cardiac lineage-specific conversion directly from the pluripotent state of hESC by small molecule induction, which opens the door for human neural and cardiac tissue/organ engineering/biofabrication and regeneration as well as to investigate molecular neurogenesis and cardiogenesis in human embryonic development using powerful in vitro model systems. Contact: parsons@xcelthera.com

Dr. Xuejun Parsons Research interest: stem cell biology, regenerative medicine, neural regeneration, human pluripotent stem cell, human embryonic stem cells, neural stem cells, neuronal progenitor, neurological disorders, neurodegenerative disease, cardiac stem cell, heart disease, neuronal regeneration, myocardium regeneration, cell therapy, tissue engineering, cancer stem cell